Welcome to our dedicated page for Healthcare Triangle news (Ticker: HCTI), a resource for investors and traders seeking the latest updates and insights on Healthcare Triangle stock.
Healthcare Triangle, Inc. (Nasdaq: HCTI) generates a steady flow of news related to healthcare information technology, digital transformation, and AI-driven health platforms. Based in Pleasanton, California, the company reports on developments that span cloud and data platforms, acquisitions, financing activities, and the evolution of its digital health ecosystem.
News about Healthcare Triangle frequently highlights its role as a provider of digital transformation solutions for hospitals and health systems, payers, and pharma/life sciences organizations. Coverage often references its HITRUST-certified Cloud and Data Platform (CloudEz™ and DataEz™), as well as its work in security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization.
Recent company communications emphasize a strategic shift toward AI-powered digital health. Articles and press releases discuss the GenAI-powered QuantumNexis platform, the Ezovion EMR and hospital information system, and digital mental health and engagement tools such as Ziloy. News items also describe milestones like Ezovion processing significant volumes of revenue for healthcare providers and plans to launch an integrated payment gateway to create transaction-based revenue streams.
Investors following HCTI news will also see updates on mergers and acquisitions and capital structure decisions. The company has announced an Asset Transfer Agreement involving Niyama Healthcare and Ezovion Solutions, and it has disclosed a non-binding Letter of Intent and an Advance Agreement related to acquiring AI-powered customer engagement businesses associated with Teyame.AI, Teyame 360 SL, and Datono Mediacion SL. Additional news covers warrant inducement transactions, convertible note financings, and at-the-market equity programs.
This news page aggregates these disclosures, sponsored articles, and regulatory announcements so readers can track Healthcare Triangle’s progress in AI-driven healthcare technology, its expansion of SaaS and fintech-enabled platforms, and its ongoing efforts to maintain Nasdaq listing compliance and support growth through capital markets activity.
Healthcare Triangle (NASDAQ:HCTI) has secured approximately $1.63 million in gross proceeds through warrant exercise agreements with three existing accredited investors. The agreement involves the immediate exercise of existing warrants to purchase 812,775 shares of common stock, with the exercise price reduced from $20.92 to $2.00 per share.
In exchange, investors will receive new unregistered warrants to purchase an additional 812,775 shares at $3.00 per share, exercisable upon stockholder approval and expiring five years thereafter. WallachBeth Capital is serving as the sole placement agent for this warrant inducement transaction, expected to close on October 2, 2025.
Healthcare Triangle (Nasdaq: HCTI) announced that its subsidiary QuantumNexis's Ezovion EMR platform has processed over $20 million in revenue from healthcare providers. The company projects this figure to reach $37 million within six months as it expands into India, Bangladesh, Saudi Arabia, and Malaysia.
QuantumNexis plans to launch a proprietary integrated payment gateway that will generate 0.05% (five basis points) of all revenue processed through the platform. The platform operates on a consumption-based model, enabling healthcare providers to digitize and manage their operations while creating a scalable revenue stream for HCTI through transaction-based fees.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.